Ischaemic Preconditioning of Myocardium
Open Access
- 1 January 1997
- journal article
- review article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 29 (4) , 345-352
- https://doi.org/10.3109/07853899708999359
Abstract
Myocardium has the innate potential to adapt to transient sublethal ischaemia so that it becomes more resistant to a subsequent, more severe, ischaemic insult. The response is called ischaemic preconditioning and protection of the myocardium is manifested by a slowing of adenosine triphosphate decline, limitation of ischaemic necrosis and a reduction in dysrhythmia severity. Protection conferred by preconditioning occurs in two distinct temporal phases. An early phase of protection is observed immediately but wanes within two to three hours (classic preconditioning). This is followed many hours later by a second window of protection (delayed preconditioning). The cellular mechanisms underpinning both forms of protection are currently being intensively investigated. There is evidence that human myocardium can be preconditioned ex vivo and also in situ during elective procedures such as angioplasty and coronary artery bypass grafting. Furthermore, evidence points to the possibility that preconditioning occurs naturally in some ischaemic syndromes, particularly warm-up angina and preinfarction angina. Ultimately, investigation of the mechanisms of preconditioning may contribute to the development of rational therapies for protecting the ischaemic myocardium and, perhaps more importantly, enhance our understanding of the molecular basis of ischaemic heart disease.Keywords
This publication has 52 references indexed in Scilit:
- Delayed protection of the ischemic heart — from pathophysiology to therapeutic applicationsFundamental & Clinical Pharmacology, 1996
- Delayed protection of the heart against ischaemiaTrends in Pharmacological Sciences, 1995
- Role of Bradykinin in Protection of Ischemic Preconditioning in Rabbit HeartsCirculation Research, 1995
- A ?second window of protection? or delayed preconditioning phenomenon: Future horizons for myocardial protection?Journal of Molecular and Cellular Cardiology, 1995
- Isolation of plasma membrane fractions from the intestinal epithelial model T84American Journal of Physiology-Cell Physiology, 1993
- Pretreatment with the adenosine A1 selective agonist, 2-chloro-N6-cyclopentyladenosine (CCPA), causes a sustained limitation of infarct size in rabbitsCardiovascular Research, 1993
- Infarct size limitation by preconditioning: its phenomenological features and the key role of adenosineCardiovascular Research, 1993
- Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction.Circulation, 1992
- Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart.Circulation, 1991
- Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.Circulation, 1986